Literature DB >> 7976663

Causative role of lysosomal enzymes in the pathogenesis of cerebral lesions due to brain edema under chronic hypertension.

E Yamada1, C H Chue, N Yukioka, F Hazama.   

Abstract

In order to clarify the role of lysosomal enzymes in the developmental mechanisms of cerebral lesions under chronic hypertensive conditions, we histochemically and biochemically investigated acid phosphatase, N-acetyl-beta-glucosaminidase, and cathepsin B in the cerebral cortex and subcortical white matter in stroke-prone spontaneously hypertensive rats (SHRSP). Histochemical investigation showed that SHRSP had an increased number of cells with positive reaction to these enzymes in the edematous cortex and degenerated subcortical white matter. The cells with positive reaction were made up of reactive astrocytes and microglias. The activities of all enzymes in the aged SHRSP were higher than those in normotensive rats, the differences being significant at 24 weeks of age. The present study suggests that chronic hypertension or chronic edema causes increased activities of lysosomal enzymes in the cerebral cortex and subcortical white matter, and that the activated lysosomal enzymes take part in the developmental mechanisms of cystic formation as well as the diffuse degeneration of the white matter.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7976663     DOI: 10.1007/978-3-7091-9334-1_21

Source DB:  PubMed          Journal:  Acta Neurochir Suppl (Wien)


  3 in total

1.  Effect of acetaldehyde upon cathepsin G and chymase. NRAS implications.

Authors:  Arthur S Brecher; Rachel Dubord
Journal:  Dig Dis Sci       Date:  2007-10-12       Impact factor: 3.199

2.  Quantitative Serum Proteomic Analysis of Essential Hypertension Using iTRAQ Technique.

Authors:  Jing-Wen Xu; Yun-Lun Li; Shi-Jun Zhang; Wen-Qing Yang; Wen-Ting Nie; Hai-Qiang Jiang
Journal:  Biomed Res Int       Date:  2017-10-22       Impact factor: 3.411

Review 3.  Cathepsin B is a New Drug Target for Traumatic Brain Injury Therapeutics: Evidence for E64d as a Promising Lead Drug Candidate.

Authors:  Gregory Hook; J Steven Jacobsen; Kenneth Grabstein; Mark Kindy; Vivian Hook
Journal:  Front Neurol       Date:  2015-09-02       Impact factor: 4.003

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.